Drug Profile
Taspoglutide
Alternative Names: BIM 51077; BM 51077; BN 51077; ITM-077; R1583; RG 1583Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Ipsen
- Developer Roche; Teijin Pharma
- Class Amino acids; Antihyperglycaemics; Glucagon-like peptides
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Type 2 diabetes mellitus